Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Castelli

Showing results (101-110 of 236) with videos related to

Pageof 24
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 1, 1999
Interferon enhances the activity of the anticancer ribonuclease, onconaseV M Vasandani, J C Castelli, J S Hott, et al.
Clinical Pharmacology and Therapeutics|September 4, 2009
Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjectsR E Steinert, B Poller, M C Castelli, et al.
International Journal of Cancer|December 2, 1991
Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactionsM Radrizzani, B Benedetti, C Castelli, et al.
International Journal of Cancer|June 11, 1999
Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-AE Jäger, H Höhn, J Karbach, et al.
Cancer Immunology, Immunotherapy : CII|July 19, 2001
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytesA Mazzocchi, C Melani, L Rivoltini, et al.
European Journal of Immunology|May 16, 1998
Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patientsC Castelli, A Mazzocchi, F Rini, et al.
European Journal of Immunology|August 1, 1985
Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structuresD Ballinari, C Castelli, C Traversari, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytesM J Maeurer, D M Martin, C Castelli, et al.
Frontiers in Genetics|December 16, 2021
Current HLA Investigations on SARS-CoV-2 and PerspectivesVenceslas Douillard, Erick C Castelli, Steven J Mack, et al.
Frontiers in Genetics|December 20, 2021
Approaching Genetics Through the MHC Lens: Tools and Methods for HLA ResearchVenceslas Douillard, Erick C Castelli, Steven J Mack, et al.
Pageof 24

Showing results (101-110 of 236) with videos related to

Sort By:
Pageof 24
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 1, 1999
Interferon enhances the activity of the anticancer ribonuclease, onconaseV M Vasandani, J C Castelli, J S Hott, et al.
Clinical Pharmacology and Therapeutics|September 4, 2009
Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjectsR E Steinert, B Poller, M C Castelli, et al.
International Journal of Cancer|December 2, 1991
Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactionsM Radrizzani, B Benedetti, C Castelli, et al.
International Journal of Cancer|June 11, 1999
Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-AE Jäger, H Höhn, J Karbach, et al.
Cancer Immunology, Immunotherapy : CII|July 19, 2001
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytesA Mazzocchi, C Melani, L Rivoltini, et al.
European Journal of Immunology|May 16, 1998
Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patientsC Castelli, A Mazzocchi, F Rini, et al.
European Journal of Immunology|August 1, 1985
Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structuresD Ballinari, C Castelli, C Traversari, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytesM J Maeurer, D M Martin, C Castelli, et al.
Frontiers in Genetics|December 16, 2021
Current HLA Investigations on SARS-CoV-2 and PerspectivesVenceslas Douillard, Erick C Castelli, Steven J Mack, et al.
Frontiers in Genetics|December 20, 2021
Approaching Genetics Through the MHC Lens: Tools and Methods for HLA ResearchVenceslas Douillard, Erick C Castelli, Steven J Mack, et al.
Pageof 24